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Background: it has been suggested that female patients have a less favourable outcome of endoluminal repair of abdominal
aortic aneurysms. Yet, data on stratified per gender are lacking.
Methods: we reviewed our prospective database of 402 endografts over a 4-year period and the peri- and postoperative
course in the 25 (6%) female patients was compared with the 377 (94%) male patients. Median follow-up was 24 months
(range 1±56 months). Logistic regression analysis was performed to test the effect of five confounding variables (gender, age,
ASA grade IV, EUROSTAR class D or E, AAA diameter) on failure of AAA exclusion.
Results: there were no perioperative deaths in the female group and 5 (1.3%) in the male group (p 0.8). Major
perioperative morbidity occurred in 17% versus 6% (OR 3.7; 95% CI 1.2±10.6; p 0.026). There were 1 (4%) and 5
(1%) conversions to open repair in the female and male groups, respectively (p 0.3). Late failure of AAA exclusion
occurred in 5 (21%) and 26 (7%) patients, respectively (p 0.03). Of the five variables examined for their influence on
failure of AAA exclusion, female gender (hazard ratio 4.42; 95% CI 1.4±13.4; p 0.009) and AAA diameter (hazard ratio
1.05; 95% CI 1.009±1.09; p 0.017), were positive independent predictors of late failure of AAA exclusion on multivariate
analysis.
Conclusion: endoluminal AAA repair in female patients appear associated with a less favorable outcome when compared to
their male counterparts. These data may be taken into consideration when enodoluminal AAA repair is suggested to a
female patient.
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Introduction
Despite an increased interest in abdominal aortic
aneurysm (AAA) Endovascular Repair (EVAR) out-
come data, few studies have addressed specifically
the issue of whether gender might represent a proxy
for other confounding variables in EVAR outcomes. It
is well known that there are gender differences in the
prevalence and severity of arterial disease. This dif-
ference is supported by the increased prevalence of
aneurysms and occlusive disease in men as compared
with women.1±4 Evidence also exists that gender dif-
ference in the prevalence of disease is accompanied by
different treatment outcome.4±7 However, whether
gender-related differences in arterial morphology
may preclude applicability and technical success of
aortic endografting in women, remains controversial.
The aim of this study was to determine whether
women are at increased risk of early and late failure
after EVAR.
Patients and Methods
Between April 1997 and April 2002, 402 consecutive
patients underwent elective EVAR for AAA at our
Unit and represent the cohort of the present study.
Twenty-five patients (6%) were female and were com-
pared with 377 (94%) male patients. Median follow-up
was 24 months (range 1±56 months). Preoperative,
operative, and follow-up data were prospectively col-
lected. Indications for treatment of AAA at our Unit
included AAA of 5 cm or greater, or AAA 4 cm that
increased rapidly in size (40.5 cm in the previous 6
months), or became tender, or associated with an iliac
aneurysm greater than 3 cm. AAA diameter at com-
puted tomography (CT) was assessed considering the
maximum external diameter of the vessel. Measure-
ments were always carried out at the widest portion of
the aneurysm. When the aneurysm circumference had
an elliptical shape, the smaller diagonal was consi-
dered, thus avoiding errors in size evaluation due to
aortic tortuosity.8 Selection criteria for EVAR included
a proximal aneurysm neck length of 15 mm or greater
and a neck diameter of 30 mm or less, aortic neck
angulation 575, iliac artery of 47 mm in diameter
without excessive tortuosity, calcification, or stenosis.
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Anatomical features were evaluated by a combina-
tion of pre-procedural imaging techniques including
contrast-enhanced, conventional, or spiral CT scan
with 5 mm cuts or less, color duplex scan, and angio-
graphy or angio-magnetic resonance with gadolinium.
Aneurysm extension was recorded according to the
EUROSTAR classification.9
The AneuRx stent graft (Medtronic, Santa Rosa, CA,
U.S.A.) was implanted in 231 procedures, the
Excluder (WL Gore and Associates, Flagstaff, AZ,
U.S.A.) in 53, the Talent graft (World Medical-
Medtronic, Sunrise, FL, U.S.A.) in 51, the Zenith graft
(William Cook Europe, Biaeverskow, Denmark) in 52,
the Anaconda in 11 (Sulzer Vascutek, Edinburgh, U.K.),
Endologix (Bard, Irvine, CA, U.S.A.) in 3, Endofit
(Endomed, Phoenix, AZ, U.S.A.) in one. Endograft
configuration included three tubes, 393 bifurcated
grafts, and six aortouniliac grafts combined with
contralateral iliac occlusion and femoral±femoral
bypass.
EVAR was performed in an operating room by a
team of vascular surgeons and interventional radio-
logists under general or epidural anesthesia. The
decision to perform epidural anesthesia was left to
the discretion of the anesthesiologist and/or patient
choice.
Intraoperative radiological imaging was performed
with a portable C-arm fluoroscopic device (9000 OEC,
Diasonics) with digital imaging and road mapping
capability on a compatible operating table. Initial
assessment of endograft function and position, and
verification of satisfactory exclusion of the AAA were
evaluated by intraoperative post-deployment angio-
graphy, pre-discharge color duplex scan and plain
abdominal radiographs.
Physical examination, color duplex scan, and plain
abdominal radiography were repeated at 1, 6, 12
months after the procedure and annually thereafter.
Contrast-enhanced CT scan was repeated 1 month
after surgery and then annually.
Outcome measures were survival, early failure (i.e.,
death or conversion within 30 days) and late failure of
AAA exclusion (i.e., AAA rupture, conversion to open
repair, increase in AAA diameter 3 mm after ER or
persisting graft-related endoleak). Other outcome
measures included major perioperative morbidity
(i.e., life threatening complications and those resulting
in permanent injury or disability or arterial occlusion
thath occurred within 30 days after procedure), blood
loss, operative time, and length of hospital stay. Endo-
leak detected either on CT or color duplex scan was
defined as the presence of contrast enhancement or
color and doppler signal within the aneurysmal sac
and outside the endograft, respectively.10
Statistics
Comparison between male and female patients was
performed by the two-sample t-test for continuous
variables and chi-squared or Fisher exact test for dis-
crete variables. Life table method with log rank test for
significance was used for survival. The influence of
five confounding variables (gender, age, ASA grade,
EUROSTAR class D or E, AAA diameter) on outcome
measures was tested by Cox regression analysis. Stat-
istical analysis was conducted with SPSS software
(SPSS Inc., Chicago, IL, U.S.A.). p 0.05 was consid-
ered statistically significant.
Results
There were no perioperative deaths in the female
group and five (1.3%) in the male group (p 0.8),
one due to intraoperative aortic neck rupture. Clinical
and anatomical features of male and female patients
are shown in Tables 1 and 2.
There was one (4%) perioperative conversion to
open repair in the female group while five (1.3%)
conversions were performed in the male group
(p 0.3). Intraoperative details stratified per study
groups are displayed in Table 3. Overall perioperative
major morbidity rate was 6.2%. Major perioperative
morbidity occurred in five (17%) female patients and
in 20 (5.7%) male patients (OR 3.7; 95% CI 1.2±10.6;
p 0.026); causes of morbidity are displayed in Table 4.
Table 1. Risk factors in 402 patients.
Female % Male % p value
n 25 n 377
Mean age 75.3 71.3 0.05
Smoking 10 40 230 61 0.03
Hypertension 22 88 238 63 0.02
Diabetes 2 8 33 9 NS
Cardiac disease 13 52 182 48 NS
Respiratory disease 12 48 203 54 NS
Renal insufficiency 2 8 41 11 NS
NS, not significant.
Table 2. Anatomical features in 402 patients.
Female % Male % p value
n 25 n 377
Mean AAA diameter
mm (range)
52.2
(40±86)
50.8
(40±84)
0.0001
EUROSTAR class D or E 3 10 58 15 NS
Severe iliac calcification 4 14 53 14 NS
Proximal neck thrombus 1 3 32 8 NS
Short proximal neck
(51.5 cm)
2 7 35 9 NS
NS, not significant.
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At a median follow-up of 24 months (range 1±56
months), overall late mortality occurred in 42 patients
(9.5%): three patients (12%) died in the female group
and 39 (11%) in the male group. Causes of late mor-
tality included three AAA ruptures, seven cardiac fail-
ures, one bowel occlusion, one pulmonary embolism,
eight myocardial infarctions, 11 cancers, two traumas,
one renal failure, one suicide, two strokes, three
respiratory insufficiencies, one intracranial haemor-
rhage, and one bleeding duodenal ulcer. Survival at
42 months was 83.5% in women and 79.1% in men
based on Kaplan±Meier analysis (pns) (Fig. 1).
Late failure of AAA exclusion occurred in five
patients (21%) in the female group and in 26 patients
(7%) in the male group (p 0.03). Causes of late failure
listed for male and female patients are displayed in
Table 5.
Overall, 4 AAA ruptures occurred: all associated
with secondary endoleak (one of Type I and three of
Type III) not evident on the first postoperative CT
scan; two of the patients had refused subsequent fol-
low up examinations prior to AAA rupture. Elective
late conversion to open repair was performed in 14
patients: two in the female group (8%) and 12 (3.1%) in
the male group. Conversion was not accomplished in
two patients with persisting Type I endoleak, because
one patient refused open treatment while the other
died for congestive heart failure before the planned
conversion. AAA growth (3 mm) occurred in 18
patients, seven required treatment. Growth by itself
was not considered an indication for conversion in 11
patients because it ranged between 3 and 5 mm and
was not associated with endoleak or other abnormal-
ities suggesting impending graft failure.
Of five variables examined for their influence on
failure of AAA exclusion, female gender (hazard
ratio 4.42; 95% CI 1.4±13.4; p 0.009) and AAA dia-
meter (hazard ratio 1.05; 95% CI 1.009±1.09; p 0.017),
were positive independent predictors of late failure of
AAA exclusion on multivariate analysis. AAA dia-
meter was also found the only independent predictor
of early failure (hazard ratio 1.1; 95% CI 1.03±1.17;
p 0.003). Female gender (hazard ratio 3.2; 95% CI
1.02±10.2; p 0,04), age (hazard ratio 1.07; 95% CI
1.01±1.14; p 0.03) and EUROSTAR Class D or E
(hazard ratio 2.5; 95% CI 1.04±6.3; p 0.04) were
positive independent predictors of perioperative
complications.
Cumulative probability of failure at 42 months was
28% in female patients and 14% in men (p 0.01)
(Fig. 2).
Discussion
Although the number of endoluminal procedures for
AAA has increased considerably in the recent years,
the proportion of operations on women has remained
Fig. 1. Actuarial survival of male and female patients.
Table 3. Intraoperative details in 402 patients.
Female Male p value
n 25 n 377
Use of adjunctive cuffs 6 (24%) 98 (26%) NS
Mean time of procedure (min) 135 131 NS
Mean fluoro time (min) 23.2 22.7 NS
Mean contrast media (cc) 150 156 NS
Mean blood loss (cc) 309 318 NS
NS, not significant.
Table 4. Causes of perioperative morbidity in 402 patients.
Female % Male %
n 25 n 377
Myocardial infarction 1 4 3 0.8
Congestive heart failure 1 4 1 0.3
Stroke 1 4 /
Iliac rupture 1 4 1 0.3
Renal infarction 1 2 0.5
Bowel occlusion / 1 0.3
Intraparenchimal renal
artery hemorrage
/ 1 0.3
Bleeding duodenal ulcer / 1 0.3
Mucosal colon ischemia / 2 0.5
Limb graft occlusion / 6 1.6
Limb amputation / 1 0.3
Subdural hematoma / 1 0.3
Table 5. Causes of late failure in 391 patients.
Female % Male %
n 24 n 367
AAA rupture 1 4 3 0.8
Elective conversion to open repair 2 8 12 3.1
Persisting type I endoleak
not corrected
1 4 1 0.3
Increase AAA diameter  3 mm
without any other abnormality
1 4 10 2.6
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low. Our data indicate that although female patients
undergoing EVAR are at no greater risk of periopera-
tive death or conversion, they are at greater risk of
major intra-operative complications. Late results in
women were not comparable with those recorded in
men. Some differences may be due to the discrepancy
in numbers of men with respect to female patients. In
general AAA occurs five to six times more commonly
in men than in women.2±4 Consequently, many series
of patients with AAA undergoing endovascular or
open repair include a relatively small number of
women.11±13
In our series freedom from failure was 72% for
female and 86% for males undergoing EVAR at
42 months, a difference that reached statistical signi-
ficance (p 0.01). Analysis beyond 42 months was
not performed with Kaplan±Meier analysis, as the
number of endovascular patients with 44-year
follow-up was small. It is possible that the female
gender has more than a propensity for complex aortic
aneurysm morphologic features. In general women
are known to have smaller arteries. EVAR eligibility
rate with respect to men is controversial. Previous
studies using different type of aortic devices showed
conflicting conclusions: Carpenter et al. in analys-
ing exclusion criteria for EVAR on 307 patients
(43 women), found a disproportionate number of
women were to be excluded because of anatomic find-
ings (24/43), the most determinant of which was the
aneurysm neck.14 Similar conclusions were detected
by Velazquez et al. who found the proximal neck signi-
ficantly wider, shorter and angulated in women than
in men undergoing EVAR with Ancure or Talent
endografting.12 In addition, the authors found a sig-
nificant smaller diameter in iliac arteries among
female. Based only on unsuitable anatomy for EVAR,
rejection rate was about two-fold for women than for
men: 63.2% versus 38.6%. Differently, Wolf et al. anal-
ysing a different type of aortic device in 26 women
and 161 men, concluded that the eligibility rate for
women was lower but not significantly different
from that of men: 49% versus 57%.11 However,
women experienced more intraoperative complica-
tions (31% vs 13%, p5 0.05) primarily related to arter-
ial access and needed more frequent arterial
reconstructions. We did not found significantly mor-
phological differences in women except for the AAA
diameter that was significantly larger. Women were
similar to men with respect to aortic neck character-
istics, vessel calcification or aneurysmal extension (see
Table 2). Although we did not measure specifically
iliac external size, our female patients experienced
only one intraoperative iliac artery rupture. Rupture
occurred in an ASA IV female patient with severe
cardiac disease (congestive heart failure after cardiac
revascularization), 6 cm AAA and 3 cm common left
iliac aneurysm. Endovascular repair was attempted
with 32/15 mm Talent stentgraft using right side
branch for principal access (right iliac femoral
bypass). Unfortunately, left external iliac rupture
occurred intraoperatively and a left iliac femoral
bypass was immediately perfomed for repair.
Similarly, only one early conversion to open repair
for impossibility to advance the device through the
arterial tree was needed in the women subgroup. It is
possible to hypothesize that arterial morphology may
not have a role on early outcomes in female patients
undergoing EVAR when an appropriate device was
selected. Furthermore, in our experience, EVAR was
not technically more demanding in women: special
exposure techniques (e.g., iliac femoral conduit for
access, etc.) were not more frequently employed in
these patients with respect to male counterpart.
EVAR in women did not require a higher number of
extender cuffs nor longer procedural or fluoro times,
greater contrast volumes or blood replacements than
men (see Table 4). Obviously, we could not detect
significant correlation between a particular brand
device and EVAR complications for women patients,
due to the wide variability of devices used in a small
sample size.
From the analysis of our patient characteristics,
women were older than men and showed aneurysms
with a larger diameter. This may be the result of late
diagnosis or late referral for surgical treatment in
women with AAA. Likely, the older age and the
more complex anatomical features may have played
a key role on the higher periprocedural morbidity and
late technical failure rates. However, our numbers are
too small to draw strong conclusions.
Women were more prone to late failure also after
successful AAA repair was performed. We found that
female patients undergoing EVAR had a four-fold
higher risk of late failure than men. Although there
Fig. 2. Actuarial freedom from late failure of male and female
patients.
72 G. Parlani et al.
Eur J Vasc Endovasc Surg Vol 26, July 2003
0
10
20
30
40
50
60
70
80
90
100
0 3 6 9 12 15 18 21 24 27 30 33 36 39 42
male
female
86%
Log rank test p = 0.01
months
%
72%
are a small number of reports focusing specifically on
gender in endovascular AAA repair, our findings
agree with other experiences. Buth et al., reporting
data from a large registry on 1554 patients undergone
EVAR (EUROSTAR), found that female gender and
age 575 years were independent risk factors for
primary endoleak (p 0.02; OR 1.7; 95% CI 1.1±2.7
and p 0.009; OR 1.9; 95% CI 1.3±2.9, respectively).15
Because of the limited number of our female cohort
and the relatively small size of aneurysm treated, our
results are probably scarcely generalizable. At this
regard, data from the U.K. Small Aneurysm Trial
showed an increased risk of rupture in small AAA
(4.0±5.5 cm) in women.16 Evidence also exists that
overall EVAR technical success is higher in AAA of
small diameter. Our data confirm that large AAA
diameter and female sex are independent positive
predictors of late EVAR failure (hazard ratio 1.05 and
hazard ratio 4.42, respectively). These findings might
justify a more aggressive repair also in women with
AAA diameter smaller than common accepted thres-
hold for repair (i.e., 5.5 cm).
In conclusion, gender influences the late outcome of
EVAR. Women with AAA in our series were older
with larger AAA diameter yet, their immediate
EVAR success rate not differ significantly from that
of men. On the other hand, EVAR in female patients
was associated with a significantly worse late outcome
when compared to their male counterparts. These
findings may be considered when suggesting endo-
luminal AAA repair to female patients.
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